Literature DB >> 20205288

Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer.

Boris Guiu1, Julie Vincent, Séverine Guiu, Sylvain Ladoire, Pablo Ortega-Deballon, Jean-Pierre Cercueil, Bruno Chauffert, François Ghiringhelli.   

Abstract

Hepatic arterial infusion (HAI) of chemotherapy can be performed in cases of liver-confined metastatic disease, resulting in increased local drug concentrations. Here we report the case of a 61-year-old man who presented with an isolated large unresectable liver metastasis of colon cancer after failure of surgery and multiple administration of systemic chemotherapy. The patient was treated with a combination of gemcitabine and oxaliplatin using HAI. The tolerance was excellent and a radiological complete response was obtained after 8 cycles of HAI. The rationale for the use of gemcitabine and oxaliplatin as well as that for the combination of the 2 drugs is discussed in this paper. HAI of gemcitabine-oxaliplatin should be evaluated in further clinical trials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20205288      PMCID: PMC2835794          DOI: 10.3748/wjg.v16.i9.1150

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer.

Authors:  W Kern; B Beckert; N Lang; J Stemmler; M Beykirch; J Stein; E Goecke; T Waggershauser; J Braess; A Schalhorn; W Hiddemann
Journal:  Ann Oncol       Date:  2001-05       Impact factor: 32.976

2.  Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver.

Authors:  C L van der Wilt; J R Kroep; W J P Loves; M G Rots; C J Van Groeningen; G J Kaspers; G J Peters
Journal:  Eur J Cancer       Date:  2003-03       Impact factor: 9.162

3.  Hepatic perfusion abnormalities during treatment with hepatic arterial infusion chemotherapy: value of CT arteriography using an implantable port system.

Authors:  H Seki; M Kimura; T Kamura; T Miura; N Yoshimura; K Sakai
Journal:  J Comput Assist Tomogr       Date:  1996 May-Jun       Impact factor: 1.826

Review 4.  Gemcitabine: preclinical pharmacology and mechanisms of action.

Authors:  W Plunkett; P Huang; C E Searcy; V Gandhi
Journal:  Semin Oncol       Date:  1996-10       Impact factor: 4.929

5.  Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric study.

Authors:  E Díaz-Rubio; J Sastre; A Zaniboni; R Labianca; H Cortés-Funes; F de Braud; C Boni; M Benavides; G Dallavalle; M Homerin
Journal:  Ann Oncol       Date:  1998-01       Impact factor: 32.976

6.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Authors:  A de Gramont; A Figer; M Seymour; M Homerin; A Hmissi; J Cassidy; C Boni; H Cortes-Funes; A Cervantes; G Freyer; D Papamichael; N Le Bail; C Louvet; D Hendler; F de Braud; C Wilson; F Morvan; A Bonetti
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

7.  Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.

Authors:  Giammaria Fiorentini; Susanna Rossi; Patrizia Dentico; Francesco Meucci; Francesco Bonechi; Paolo Bernardeschi; Maurizio Cantore; Stefano Guadagni; Michele De Simone
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

8.  Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model.

Authors:  Radan Dzodic; Gonzalo Gomez-Abuin; Philippe Rougier; Marc Bonnay; Patrice Ardouin; Alain Gouyette; Olivier Rixe; Michel Ducreux; Jean-Nicolas Munck
Journal:  Anticancer Drugs       Date:  2004-07       Impact factor: 2.248

Review 9.  Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

Authors:  Simone Mocellin; Pierluigi Pilati; Mario Lise; Donato Nitti
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

10.  Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.

Authors:  Irene Guthoff; Erkki Lotspeich; Claudia Fester; Inger Wallin; Miriam Schatz; Hans Ehrsson; Marko Kornmann
Journal:  Anticancer Res       Date:  2003 Nov-Dec       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.